Skip to main content

Table 3 Motivations for participation in an HIV vaccine trial by sex

From: Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania

Categorical statements

Men n(%)

Women n(%)

Total n(%)

Volunteerism to rescue lives of others [altruism]

64 (34.8)

32 (55.2)

96 (39.7)**

Desire to become a role model, to be among the enthusiasts

32 (17.4)

13 (22.4)

45 (18.6)

Researchers’ explanations about HIV/AIDS vaccine studies

36 (19.6)

1 (1.7)

37(15.3)***

To get more knowledge about HIV prevention/vaccine

27 (14.7)

10 (17.2)

37 (15.3)

To know my health status [know health status]

29 (15.8)

7 (12.1)

36 (14.9)

To get knowledge for educating others about HIV or vaccine

29 (15.8)

5 (8.6)

34 (14.0)

To cooperate with researchers in developing an HIV vaccine

21 (11.4)

2 (3.4)

23 (9.5)*

To accomplish personal motivation

14 (7.6)

5 (8.6)

19 (7.9)

To get protection against HIV infection

13 (7.1)

4 (6.9)

17 (7.0)

Magnitude of the disease [AIDS]

14 (7.6)

3 (5.2)

17 (7.0)

Severity of the disease in families – experienced death of a relative due to AIDS

13 (7.1)

2 (3.4)

15 (6.2)

Others (free treatment/insurance, test the strength of vaccine in the body)

6 (3.3)

1 (1.7)

7 (2.9)

  1. Significance denoted by: *** = P < 0.001; ** = P < 0.01; * = P < 0.05
  2. NB: The columns represent multiple responses, and thus cannot add up to 100 %. The same applies to the total number of respondents in each column